SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Catalyst Pharmaceutical Partners, Inc. Release: Scientific Paper Describing the Ocular Safety of Short-Term Vigabatrin Treatment for Cocaine Addiction in Online Edition of American Journal of Ophthalmology